Trademark Details For GENFIT TOWARDS BETTER MEDICINE (Serial Number 87401101)

Pharmaceutical and veterinary preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; cultures of microorganism for medical, pharmaceutical or veterinary use; cells preparations for medical, pharmaceutical or veterinary use, in particular for gene therapy or cell therapy; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; food supplements;

Pharmaceutical research, namely, research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical and veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; screening and selection of molecules for scientific research purposes; development and validation of biological tests, of cell tests and of genetic tests; Functional analysis of genomics to identify, characterize, validate or develop biologically active molecules; analysis of biological substances in biologic fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering surveying; analysis of technical projects; professional consultancy, not connected with the conduct of business, in the field of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacy;

Professional consultancy, not connected with the conduct of business, in the field of hepatology, gastroenterology, cholestatic, cardiovascular, metabolic, inflammation, autoimmune therapy;